Consolidated Balance Sheet

XLS

 

 

 

€ million

Sept. 30,
2012

Dec. 31,
2011*

*

 Previous year’s figures have been adjusted, see explanations in the notes.

Current assets

 

 

Cash and cash equivalents

1,484.7

937.8

Marketable securities and financial assets

1,443.3

1,117.1

Trade accounts receivable

2,206.7

2,328.3

Inventories

1,609.6

1,691.1

Other current assets

275.1

252.0

Income tax receivables

118.4

72.7

 

7,137.7

6,399.0

Non-current assets

 

 

Intangible assets

11,178.5

11,764.3

Property, plant and equipment

2,950.8

3,113.4

Non-current financial assets

102.1

60.3

Other non-current assets

57.4

54.9

Deferred tax assets

846.5

730.0

 

15,135.3

15,722.9

 

 

 

Total assets

22,273.1

22,121.9

 

 

 

Current liabilities

 

 

Current financial liabilities

1,674.0

1,394.4

Trade accounts payable

1,297.9

1,100.8

Other current liabilities

918.4

1,102.1

Income tax liabilities

429.4

399.4

Current provisions

678.0

365.5

 

4,997.8

4,362.2

Non-current liabilities

 

 

Non-current financial liabilities

3,380.9

4,144.9

Other non-current liabilities

21.8

43.6

Non-current provisions

820.1

617.0

Provisions for pensions and other post-employment benefits

1,280.4

1,140.3

Deferred tax liabilities

1,206.0

1,319.6

 

6,709.2

7,265.4

Net equity

 

 

Equity capital

565.2

565.2

Reserves

8,683.2

8,672.6

Gains/losses recognized immediately in equity

1,265.3

1,210.2

Equity attributable to Merck KGaA shareholders

10,513.7

10,448.0

Non-controlling interest

52.5

46.3

 

10,566.1

10,494.3

 

 

 

Total liabilities and stockholders’ equity

22,273.1

22,121.9